S100A5 Attenuates Efficiency of Anti-PD-L1/PD-1 Immunotherapy by Inhibiting CD8<sup>+</sup> T Cell-Mediated Anti-Cancer Immunity in Bladder Carcinoma.

Adv Sci (Weinh) · 2023 · PMC10477882 · PMID 37414584

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

As expected, the greater the distance from S100A5 + CK19 + cells, the more CD4 + and CD8 + T cells showed an increasing trend (Figure 5K ), which confirmed the spatially exclusive relationship between S100A5 and effector T cells. 2.9.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.